Red Tortoise LLC’s Immunovant IMVT Stock Holding History

Red Tortoise LLC’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.01K	Hold	242	–	–	﹤0.01%	357
2025 Q4	$6.15K	Hold	242	–	–	﹤0.01%	352
2025 Q3	$3.9K	Hold	242	–	–	﹤0.01%	425
2025 Q2	$3.87K	Hold	242	–	–	﹤0.01%	404
2025 Q1	$4.14K	Hold	242	–	–	﹤0.01%	365
2024 Q4	$5.99K	Hold	242	–	–	﹤0.01%	328
2024 Q3	$6.9K	Hold	242	–	–	﹤0.01%	315
2024 Q2	$6.39K	Hold	242	–	–	﹤0.01%	315
2024 Q1	$7.82K	Hold	242	–	–	﹤0.01%	270
2023 Q4	$10.2K	Sell	242 -108	-31%	-$3.97K	0.01%	181
2023 Q3	$13.4K	Hold	350	–	–	0.01%	152
2023 Q2	$6.64K	Hold	350	–	–	﹤0.01%	240
2023 Q1	$5.43K	Hold	350	–	–	﹤0.01%	255
2022 Q4	$6.21K	Buy	+350	New	+$4.41K	﹤0.01%	284
2021 Q4	–	Sell	-350	Closed	-$2K	–	279
2021 Q3	$2K	Buy	+350	New	+$3.16K	﹤0.01%	432

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Red Tortoise LLC's IMVT Position: Q1 2026 in Review

Red Tortoise LLC held its Immunovant (IMVT) position steady in Q1 2026 at 242 shares worth $6.01K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

Red Tortoise LLC first reported a position in IMVT in Q3 2021 and has held it in 15 quarters since. The position peaked at $13.4K in Q3 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Red Tortoise LLC held 242 shares of Immunovant worth $6.01K as of Q1 2026.
Red Tortoise LLC left its Immunovant share count unchanged in Q1 2026.
Immunovant made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #357 holding.
Red Tortoise LLC first reported a position in Immunovant in Q3 2021 and has held it in 15 quarters since.
Red Tortoise LLC's Immunovant position peaked at $13.4K in Q3 2023.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.